A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1133-1139

  Narita, Motoshi ^a   Murata, Taku ^a   Shimizu, Kasumi ^a   Nakagawa, Toshiyuki ^a   Sugiyama, Takeo ^a   Inui, Madoka ^a   Hiramoto, Kenichi ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Human malignant melanoma; Phosphodiesterase 4; Phosphodiesterase 4 inhibitor

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 8 (4 CHLORO PHENYLTHIO) 2' O METHYLADENOSINE 3' 5' CYCLIC MONOPHOSPHATE; 8-(4-CHLORO-PHENYLTHIO)-2'-O-METHYLADENOSINE-3'-5'-CYCLIC MONOPHOSPHATE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DRUG DERIVATIVE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOSYNTHESIS; CELL GROWTH; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; GINGIVA; HUMAN; MELANOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ALTERNATIVE SPLICING; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GINGIVA; HUMANS; MELANOMA; PROTEIN KINASE INHIBITORS; RNA, MESSENGER;

EID: 34548546877     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1133     Document Type: Article

References (28)

1. Manganiello VC and Degerman E: Cyclic nucleotide phosphodiesterases (PDEs): Diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents. Tromb Haemost 82: 407-411, 1999.
2. Cho-Chung YS: Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res 50: 7093-7100, 1990.
3. de Rooji J, Zwartkruis FJT, Verheijen MHG, Cool RH, Nijman SMB, Wittinghofer A, et al: Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477, 1998. (Pubitemid 28553318)
4. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, et al: A family of cAMP-binding proteins that directly activate Rap1. Science 282: 2275-2279, 1998. (Pubitemid 29004080)
5. Eisinger M and Marko O: Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 79: 2018-2022, 1982. (Pubitemid 12088560)
6. Halaban R, Ghosh S, Duray P, Kirkwood JM and Lerner AB: Human melanocytes cultured from nevi and melanomas. J Invest Dermatol 87: 95-101, 1986. (Pubitemid 16090885)
7. Livi GP, Kmetz P, McHale MM, Cieslinski LB, Sathe GM, Taylor DP, et al: Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase. Mol Cell Biol 10: 2678-2686, 1990.
8. Houslay MD: PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol 69: 249-315, 2001.
9. Narita M, Murata T, Shimizu K, Sugiyama T, Nakagawa T, Manganiello VC, et al: Phosphodiesterase 4 in osteoblastic osteosarcoma cells as a potential target for growth inhibition. Anticancer Drugs 14: 377-381, 2003. (Pubitemid 36683750)
10. Drees M, Zimmermann R and Eisenbrand G: 3′, 5′-cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res 53: 3058-3061, 1993. (Pubitemid 23210312)
11. Tagawa T, Yatani R, Nishioka H and Murata M: Primary malignant melanoma of the oral cavity. Case report and establishment of melanoma cell line. Int J Oral Surg 10: 16-20, 1981. (Pubitemid 12066500)
12. Degerman E, Moos M Jr, Rascón A, Vasta V, Meacci E, Smith CJ, et al: Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase. Biochim Biophys Acta 1205: 189-198, 1994. (Pubitemid 24115007)
13. Ekholm D, Mulloy JC, Gao G, Degerman E, Franchini G and Manganiello VC: Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes. Biochem Pharmacol 58: 935-950, 1999. (Pubitemid 29361460)
14. Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, et al: Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem J 328: 549-558, 1997. (Pubitemid 27515599)
15. Miro X, Casacuberta JM, Gutiérrez-López MD, de Landázuri MO and Puigdomenech P: Phosphodiesterases 4D and 7A splicing variants in the response of HUVEC cells to TNF-α. Biochem Biophys Res Commun 274: 415-421, 2000. (Pubitemid 30614333)
16. McLaughlin MM, Cieslinski LB, Burman M, Torphy TJ and Livi GP: A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. J Biol Chem 268: 6470-6476, 1993.
17. Némos G, Zhang R, Sette C and Conti M: Identification of cyclic AMP-phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cells. FEBS Lett 384: 97-102, 1996. (Pubitemid 26111938)
18. Houslay MD, Scotland G, Erdogan S, Huston E, Mackenzie S, McCallum JF, et al: Intercellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase. Biochem Soc Trans 25: 374-381.
19. Wang D, Deng C, Bugaj-Gaweda B, Kwan M, Gunwaldsen C, Leonard C, et al: Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7. Cell Signal 15: 883-891, 2003. (Pubitemid 36776662)
20. Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM and Mihm MC: Malignant melanoma. Arch Pathol Lab Med 125: 1295-1306, 2001.
21. Davies SP, Reddy H, Caivano M and Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
22. Enserink JM, Christensen AE, de Rooij J, vas Triest M, Schwede F, Genieser HG, et al: A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 1-6, 2002.
23. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al: Mutation of the BRAF gene in human cancer. Nature 417: 949-954, 2002. (Pubitemid 34716871)
24. Busca R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Eychene A, et al: Ras mediates the cAMP-dependent activation of extracelluler signal-regulated kinases (ERKs) in melanocytes. EMBO J 19: 2900-2910, 2000. (Pubitemid 30386762)
25. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, et al: Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392: 622-626, 1998. (Pubitemid 28207722)
26. Busca R and Ballotti R: Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigm Cell Res 13: 60-69, 2000. (Pubitemid 30324886)
27. Murata T, Shimizu K, Narita M, Manganiello VC and Tagawa T: Characterization of phosphodiesterase 3 in human malignant melanoma cell line. Anticancer Res 22: 3171-3174, 2002. (Pubitemid 36070089)
28. Chini CC, Grande JP, Chini EN and Dousa TP: Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis. J Biol Chem 272: 9854-9859, 1997. (Pubitemid 27171652)